ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves COVID-19 Trial after Successful Emergency Use of Umbilical Stem Cells
May 20, 2020RESTEM has received approval from the U.S. Food and Drug Administration (FDA) for a 60-patient Phase I/IIa study using umbilical cord mesenchymal stem cells to treat patients with severe cases of COVID-19. The study will be the first of its kind in the US
Pharma Sources Insight January 2025
